G2 Investment Partners Management LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 170 filers reported holding CARDLYTICS INC in Q3 2021. The put-call ratio across all filers is 2.31 and the average weighting 0.6%.

Quarter-by-quarter ownership
G2 Investment Partners Management LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q2 2021$5,077,000
+106.1%
40,000
-43.2%
0.84%
+2.8%
Q1 2020$2,463,000
-19.8%
70,458
-62.1%
0.82%
-13.8%
Q1 2019$3,071,000
+502.2%
185,694
+294.5%
0.94%
+345.8%
Q4 2018$510,000
-87.4%
47,073
-74.7%
0.21%
-84.1%
Q2 2018$4,046,000185,9391.34%
Other shareholders
CARDLYTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders